Hodnota metriky Výnosy R/R spoločnosti Novo Nordisk je 24.21%
Rast ročných príjmov za posledné 3 roky (Revenue Y/Y) je rast príjmov z roka na rok spriemerovaný za posledné 3 roky.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.